Jaguar Health (JAGX) Preferred Dividend Payments (2014 - 2026)

Jaguar Health (JAGX) reported Preferred Dividend Payments of $6.1 million for Q1 2026, up 935.12% quarter-over-quarter from -$726000.0 in Q4 2020.

Jaguar Health (JAGX) Preferred Dividend Payments (2014 - 2026) Analysis & Trends

Jaguar Health (JAGX) has 6 years of Preferred Dividend Payments data on file, last reported at $6.1 million in Q1 2026.

Preferred Dividend Payments for Q1 2026 came in at $6.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $5.7 million (up 4412.7% YoY), and the FY2025 annual result was $141000.0, changed N/A from the prior year.
Preferred Dividend Payments improved to $6.1 million in Q1 2026 per JAGX's latest filing, from -$726000.0 in the prior quarter.
Over five years, Preferred Dividend Payments peaked at $6.1 million in Q1 2026 and troughed at $6.1 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Alterity Therapeutics	723,416.35 Bn	723,416.32 Bn	-	-
2	Belite Bio	57,340.00 Bn	57,340.00 Bn	-	-
3	Quantum Biopharma	19,125.08 Bn	19,125.08 Bn	-	-
4	Legend Biotech	3,262.00 Bn	3,261.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,789.67 Bn	1,789.67 Bn	-	-
6	Evaxion A	1,480.39 Bn	1,480.37 Bn	-	-
7	Psyence Biomedical	241.78 Bn	241.78 Bn	-	-
8	Vertex Pharmaceuticals	113.54 Bn	106.29 Bn	2.59 Bn	-
9	Abivax	94.26 Bn	94.26 Bn	-	-
10	Jaguar Health	1.44 Mn	-10.19 Mn	19.11 Mn	6.06 Mn

Download Data